期刊名称：EXPERIMENTAL CELL RESEARCH
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Experimental Cell Research promotes the understanding of cell biology by publishing experimental studies on the general organization and activity of cells. The scope of the journal includes all aspects of cell biology, from the molecular level to the level of cell interaction and differentiation.
Research Areas include:
*Biosynthesis with reference to cell growth
* Cell adhesion, cell-cell recognition, and cell-cell interaction
* Cell cycles
* Cell transformation in vitro and the transformed phenotype
* Energetic aspects of cell structure and function
* Functional role of subcellular particles
* Interactions among cells in tissues or in culture
* Mechanisms of meiosis and mitosis
* Modulations in cultured cells
* Molecular biology of the cell surface
* Motility
* Physical and chemical aspects of cellular and intercellular structure
* Protein sorting between cytoplasmic and nuclear compartments
* Regulation of cell growth and differentiation
* Signal transduction from the cytoplasm to the nucleus
* Supramolecular organization of chromosomes in the interphase nucleus
Instructions to Authors
Experimental Cell Research (ECR) is dedicated to publishing manuscripts that significantly advance our understanding of cell and molecular biology. Examples of areas of interest to ECR are the cell cycle; gene regulation; chromatin; subcellular organization; signal transduction; nuclear import-export; intracellular trafficking; programmed cell death; the dynamics and function of the cytoskeleton, cell membrane, and extracellular matrix; the biology of meiosis and mitosis; cell motility and migration; mechanisms of cellular growth control and differentiation; and cell-cell interaction between cells in tissues or in culture. Manuscripts in the area of cancer research, particularly those that address fundamental aspects of cell and molecular biology, are also welcomed. Reports describing new experimental techniques and methods or of theoretical work having a direct bearing on experimental approaches are also appropriate for inclusion in the journal. Experimental manuscripts will be given the highest priority and can range from the subcellular to the organism level, including work on transgenic animals. Purely descriptive work, including descriptions of RNA or protein expression patterns, is given lower priority but can be accepted if it provides important new or unexpected information.
Acceptance of manuscripts will be based on scientific excellence and priority as judged by editors and reviewers, on relevance to the central themes of the journal, and on the interest of the results to a broad readership of cell and molecular biology. A manuscript of high intrinsic quality may be returned if it seems better suited to a more specialized journal. Also, manuscripts that present preliminary observations or an incremental increase in understanding are not encouraged.
Submission of Manuscripts
Manuscripts must be written in English and should be submitted in quadruplicate (one original and three photocopies), including four sets of good-quality figures, to either office:
Editorial Office
Experimental Cell Research
Karolinska Institute
CMB, von Eulers vag 3
17177 Stockholm, Sweden
E-mail: ecr@cmb.ki.se
or
Dr. Graham Carpenter
Associate Editor for North America
Experimental Cell Research
U.S. Editorial Office
525 B Street, Suite 1900
San Diego, CA 92101-4495, USA
Telephone: (619) 699-6424
Fax: (619)699-6700
E-mail: ecr@elsevier.com
There are no submission fees or page charges. Each manuscript should be accompanied by a letter outlining the basic findings of the paper and their significance.
Authors are encouraged to suggest four competent reviewers in their field (include telephone number, fax number, and/or e-mail address for potential reviewers) and may also suggest individuals whom they wish to have excluded from the review process.
Electronic Submission. Authors are requested to transmit the text and art of the manuscript in electronic form, via computer disk, e-mail ecr@elsevier.com, or FTP (ftp.elsevier.com, with username anon and password essd4acc), each time a new version is submitted. Submission as an e-mail attachment is acceptable provided that all files are included in a single archive the size of which does not exceed 2 megabytes. Hard-copy printouts of the manuscript and art that exactly match the electronic file must be supplied. The manuscript will be edited according to the style of the journal, and authors must read the proofs carefully.
Original papers only will be considered. Manuscripts are accepted for review on the understanding that the same work has not been published, that it is not under consideration for publication elsewhere, and that its submission for publication has been approved by all of the authors and by the appropriate authority at the institution where the work was carried out. Authors must verify the wording of any cited personal communication with the persons who supplied the information and obtain approval for the use of their names in connection with the quoted information or for the citation of unpublished work; written evidence of such approval should accompany the manuscript. All material published in ECR represents the opinions of the authors and should not be construed to reflect the opinions of the Editors or the Publisher.
Authors submitting a manuscript do so on the understanding that if it is accepted for publication, copyright in the article, including the right to reproduce the article in all forms and media, shall be assigned exclusively to the Publisher. The Copyright Transfer Agreement should be signed by the appropriate person(s).
Authors are responsible for obtaining permissions to reprint previously published figures, tables, and other material.
Manuscripts can be published in the format of regular articles. There is no strict size limitation on regular articles, although they usually do not exceed 15,000 words, preceded by an abstract not to exceed 200 words. ECR also publishes review articles. As with regular articles, there is no strict size limitation, but review articles in the minireview format (3-4 pages written text) receive priority. Most review articles are solicited, but authors interested in contributing review articles or suggesting appropriate topics are encouraged to contact the Editor-in-Chief. Review articles will be subject to review before publication.
Preparation of Manuscripts
Manuscripts should be double-spaced throughout on one side of 8.5 x 11-inch or A4 white paper. Pages should be numbered consecutively and organized as follows:
The Title Page (p. 1) should contain the article title, authors' names and complete affiliations, footnotes to the title, and the address for manuscript correspondence (including e-mail address and telephone and fax numbers).
The Abstract (p. 2) must be a single paragraph that summarizes the main findings of the paper in less than 200 words. After the abstract a list of up to 10 keywords that will be useful for indexing or searching should be included.
The Introduction should be as concise as possible, without subheadings.
Materials and methods should be sufficiently detailed to enable the experiments to be reproduced.
Results and Discussion may be combined and may be organized into subheadings.
Acknowledgments should be brief and should precede the references.
References to the literature should be cited by number in square brackets in the text and listed in numerical order at the end. Use the most recent edition of the Chemical Abstracts Service Source Index for abbreviations of journal titles. Please note the following examples:
[1] K.H. Tan, W. Hunziker, Compartmentalization of fas and fas ligand may prevent auto- or paracrine apoptosis in epithelial cells, Exp. Cell Res. 284 (2003) 281-288.
[2] E.A. Holleran, S. Karki, E.L.F. Holzbaur, The role of the dynactin complex in intracellular motility, in: K.W. Jeon (Ed.), International Review of Cytology, Academic Press, San Diego, 1998, Vol. 182, pp. 69-109.
[3] G.N. Stephanopoulos, A.A. Aristidou, J. Nielsen, Metabolic Engineering: Principles and Methodologies, Academic Press, San Diego, 1998.
Figures
Figures should be in a finished form suitable for publication. Number figures consecutively with Arabic numerals, and indicate the top and the authors on the back of each figure. Lettering on drawings should be professional quality or generated by high-resolution computer graphics and must be large enough to withstand appropriate reduction for publication. Please refer to http://authors.elsevier.com/ArtworkInstructions.html?dc=AI1 for detailed instructions on preparing electronic artwork.
Color Figures
One color plate will be published free of charge in each article, provided color is deemed scientifically necessary by the reviewers and the Editorial Board. Additional color figures will be charged to the author.
Suggestions for possible cover photos are welcomed. Color figures for exclusive use as cover illustrations may be submitted by authors who are also submitting a manuscript for consideration. These figures do not need to relate to the manuscript being submitted but should relate to the larger scope and focus of ECR.
Tables
Tables should be numbered consecutively with Arabic numerals in order of appearance in the text. Type each table double-spaced on a separate page with a short descriptive title typed directly above and with essential footnotes below. Authors should submit complex tables as camera-ready copy.
Proofs
Proofs will be sent to the author. To avoid delay in publication, only necessary changes should be made, and proofs should be returned promptly. Authors will be charged for alterations in excess of 10% of the cost of composition.
Policy
It is understood that novel biological reagents described in manuscripts accepted for publication in ECR, e.g., DNA and antibodies, will be made available to scientists in academic research. All novel genetic sequence information must be deposited with GenBank or the EMBL database.
Editorial Board
-
- Editor-in-Chief:
- U. Lendahl, Department of Cell and Molecular Biology, Medical Nobel Institute, Stockholm, Sweden
- Associate Editor for North America:
- G. Carpenter, Department of Biochemistry, Vanderbilt University School of Medicine, Tennessee, USA
- Associate Editor:
- C. Höög, Department of Cell and Molecular Biology, Medical Nobel Institute, Stockholm, Sweden
- Editorial Board:
- D.P. Barlow, The Netherlands Cancer Institute
J. Bartek, Danish Cancer Society
R. Baserga, Thomas Jefferson University
H.M. Blau, Stanford University
J. Campisi, Lawrence Berkeley National Laboratory
L. Claesson-Welsh, Uppsala University
H. Clevers, University Medical Center Ultecht
P. Comoglio, University of Torino Medical School
J.A. Cooper, Washington University School of Medicine
V.J. Cristofalo, Lankenau Medical Research Center
Z. Darzynkiewicz, New York Medical College
D.T. Denhardt, Rutgers University
P.-P. Difiore, Instituto FIRC di Oncologia Moleculare
G. Dreyfuss, University of Pennsylvania School of Medicine
W.C. Earnshaw, University of Edinburgh
S. Fakan, Universite de Lausanne
R. Fässler, Max Planck Institut für Biochemie
N.E. Fusenig, Deutsches Krebsfosbungszentrum
G. Gabbiani, Universite de Geneve
B. Geiger, The Weizmann Institute of Science
F. Grinnell, University of Texas Southwestern Medical
F. Guillemot, Institute de Génétique et de Biologie Moléculaire et Cellulaire CNRS
J.L. Hamlin, University of Virginia
N. Hirokawa, University of Tokyo
J.H.J. Hoeijmakers, Erasmus Universiteit
G. Kroemer, Institute Gustave-Roussy
D.P. Lane, University of Dundee
L.F. Lau, University of Illinois at Chicago
D.A. Lauffenburger, Massachusetts Institute of Technology
C. Lehner, University of Bayreuth - Germany
B.L. Margolis, University of Michigan
M. McBurney, Ottawa Regional Cancer Centre
W.H. Moolenaar, The Netherlands Cancer Institute
S. Nagata, Osaka University
E. Nishida, Kyoto University
C.P. Ordahl, University of California at San Francisco
M. Oren, Weizmann Institute of Science
S. Orrenius, Karolinska Institute
M. Osborn, Max Planck Institute - Goettingen
H.I. Ozer, UMDNJ - New Jersey Medical School
M.G. Parker, Imperial Cancer Research Fund
L. Philipson, Karolinska Institute
E. Ruoslahti, The Burnham Institute
P. Sassone-Corsi, Institute de Génétique et de Biologie Moléculaire et cellulaire CNRS
J.M. Sedivy, Brown University
M. Serrano, Centro Nacional de Biotechnologie, CSIC
G.S. Stein, University of Massachusetts Medical Center
G. Studzinski, UMDNJ - New Jersey Medical School
L. van Aelst, Cold Spring Harbor Laboratory
E.F. Wagner, Research Institute for Molecular Pathology, Vienna
- Founding Editors:
- T. Caspersson
J. Runnström
- Editor Emeritus:
- N. Ringertz
|
